Corneal Opacity: Cell Biological Determinants of the Transition From Transparency to Transient Haze to Scarring Fibrosis, and Resolution, After Injury.
Wilson SE, Sampaio LP, Shiju TM, Hilgert GSL, de Oliveira RC.
Invest Ophthalmol Vis Sci. 2022 Jan 3;63(1):22. doi: 10.1167/iovs.63.1.22.
Topical losartan inhibits corneal scarring fibrosis and collagen type IV deposition after Descemet's membrane-endothelial excision in rabbits.
Sampaio LP, Hilgert GSL, Shiju TM, Murillo SE, Santhiago MR, Wilson SE.
Exp Eye Res. 2022 Mar;216:108940. doi: 10.1016/j.exer.2022.108940. Epub 2022 Jan 21.
Topical Losartan and Corticosteroid Additively Inhibit Corneal Stromal Myofibroblast Generation and Scarring Fibrosis After Alkali Burn Injury.
Sampaio LP, Hilgert GSL, Shiju TM, Santhiago MR, Wilson SE.
Transl Vis Sci Technol. 2022 Jul 8;11(7):9. doi: 10.1167/tvst.11.7.9.
Topical Losartan for Treating Corneal Fibrosis (Haze): First Clinical Experience.
Pereira-Souza AL, Ambrósio R Jr, Bandeira F, Salomão MQ, Souza Lima A, Wilson SE.
J Refract Surg. 2022 Nov;38(11):741-746. doi: 10.3928/1081597X-20221018-02. Epub 2022 Nov 1.
The Corneal Basement Membranes and Stromal Fibrosis.
Medeiros CS, Marino GK, Santhiago MR, Wilson SE.
Invest Ophthalmol Vis Sci. 2018 Aug 1;59(10):4044-4053. doi: 10.1167/iovs.18-24428.
Utility of nanomedicine targeting scar-forming myofibroblasts to attenuate corneal scarring and haze.
Ibrahim Al-Mashahedah AM, Kanwar RK, Kanwar JR.
Nanomedicine (Lond). 2019 Apr;14(8):1049-1072. doi: 10.2217/nnm-2017-0305. Epub 2019 Mar 22.
Regenerative Therapy for Corneal Scarring Disorders.
Chandran C, Santra M, Rubin E, Geary ML, Yam GH.
Biomedicines. 2024 Mar 14;12(3):649. doi: 10.3390/biomedicines12030649.
Corneal stromal wound healing: Major regulators and therapeutic targets.
Kamil S, Mohan RR.
Ocul Surf. 2021 Jan;19:290-306. doi: 10.1016/j.jtos.2020.10.006. Epub 2020 Oct 28.
Corneal epithelial basement membrane: Structure, function and regeneration.
Wilson SE, Torricelli AAM, Marino GK.
Exp Eye Res. 2020 May;194:108002. doi: 10.1016/j.exer.2020.108002. Epub 2020 Mar 13.
Hyperosmolar Potassium Inhibits Corneal Myofibroblast Transformation and Prevent Corneal Scar.
Liao K, Cui Z, Wang Z, Peng Y, Tang S, Chen J.
Curr Eye Res. 2023 Mar;48(3):238-250. doi: 10.1080/02713683.2022.2129072. Epub 2022 Dec 15.
